Feature Medicure to leverage sales model to new products By Len Zehr Medicure (TSXV:MPH) intends to leverage its unique sales and marketing model, which has fueled the growth of its Aggrastat IV platelet inhibitor, as it brings new generic products into its cardiovascular... June 13, 2017